The mechanistic target of rapamycin (mTOR) inhibitor rapamycin can reduce seizures, including IS, in patients with TSC [86], so this compound was trialed in the multiple-hit model; rapamycin suppressed spasms in a dose-dependent fashion and it significantly improved cognitive measures [87]. The gene discussed is MTOR; the disease is tuberous sclerosis.